Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00690092 · ClinicalTrials.gov registry record · Phase 3
A Multi-center Study of Spherule-Derived Coccidioidin
A Phase 3 study, sponsored by Nielsen BioSciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 113
- Enrollment target
NCT00690092: Completed Phase 3 study, sponsored by Nielsen BioSciences.
NCT00690092 is a Phase 3 study that has completed, run by Nielsen BioSciences. The registered enrollment target is 113 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00690092, a Phase 3 study, has completed, sponsored by Nielsen BioSciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 113 participants
- Enrollment target
Study Summary
Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Induration greater than or equal to 5 mm after 48 hours was considered positive for exposure to C. immitis.
Interventions
- BIOLOGICAL Spherule-derived coccidioidin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
What the finished NCT00690092 record still lists
NCT00690092 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Spherule-derived coccidioidin is the first listed.
NCT00690092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00690092 about?
NCT00690092 is a clinical study titled "A Multi-center Study of Spherule-Derived Coccidioidin". Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Indurat...
What is the current status of trial NCT00690092?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 113 participants. The study started on 2005-05. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00690092?
The interventions under investigation include: Spherule-derived coccidioidin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00690092?
This trial is sponsored by Nielsen BioSciences, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00690092's enrollment target sits among peer trials
113 1651st of 2000 higher than 349 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia